Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04557241 · ClinicalTrials.gov registry record · NA
Brief Informational Intervention for COVID-19 Misinformation Prophylaxis
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,017
- Enrollment target
NCT04557241: Completed NA study, sponsored by Indiana University.
NCT04557241 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,017 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04557241, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,017 participants
- Enrollment target
Study Summary
As the coronavirus disease 2019 (COVID-19) pandemic has continued to affect life in the United States, the important role of non-pharmaceutical preventive behaviors (such as wearing a face mask) in reducing harm has become clear. In parallel to the pandemic, researchers have observed an "infodemic" of misinformed or inconsistent narratives about COVID-19. There is growing evidence that misinformed COVID-19 narratives are associated with a wide variety of undesirable behavior (e.g., burning down cell towers). Further, individuals' adherence to recommended COVID-19 preventive guidelines has been inconsistent, and such mandates have engendered opposition and controversy. Recent research suggests the possibility that trust in science and scientists may be an important thread to weave throughout these seemingly disparate components of the modern public health landscape. Thus, this paper describes the protocol for a randomized trial of a brief, digital intervention to increase trust in science. The objective of this trial is to examine if exposure to a curated infographic can increase trust in science, reduce believability of misinformed narratives, and increase likelihood to engage in preventive behaviors.
Primary Outcome
21-item scale developed by Nadelson et al \[1\] called the Trust in Science Inventory. It is scored from 1 to 5, where 1 indicates low trust and 5 indicates high trust.
Interventions
- BEHAVIORAL Brief informational infographic
- BEHAVIORAL Placebo control (non-behavioral infographic)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,017 participants |
| Start Date | 2020-01-14 |
| Est. Completion | 2021-01-31 |
| Phase | NA |
What the finished NCT04557241 record still lists
NCT04557241 is an interventional study that assigns participants to a tested intervention. Its 1,017 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (28% lower).
The record links to 0 conditions, and to 2 interventions - of which Brief informational infographic is the first listed.
NCT04557241 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04557241 about?
NCT04557241 is a clinical study titled "Brief Informational Intervention for COVID-19 Misinformation Prophylaxis". As the coronavirus disease 2019 (COVID-19) pandemic has continued to affect life in the United States, the important role of non-pharmaceutical preventive behaviors (such as wearing a face mask) in reducing harm has become clear. In parallel to the pandemic, researchers have observed an "infodemic" ...
What is the current status of trial NCT04557241?
This trial is currently completed. It is a NA study. The enrollment target is 1,017 participants. The study started on 2020-01-14. Estimated completion is 2021-01-31.
What interventions are being tested in trial NCT04557241?
The interventions under investigation include: Brief informational infographic (BEHAVIORAL), Placebo control (non-behavioral infographic) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04557241?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04557241's enrollment target sits among peer trials
1,017 106th of 2000 higher than 1,895 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI